Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Group A will receive sugammadex as reversal agent: Group A participants will receive 2mg/kg of Sugammadex IV at the end of surgery after achieving 1-2 TOF count, or 4 mg/Kg when no twit
Sponsors
All India Institute of Medical Sciences Rishikesh
Eligibility
Inclusion criteria
Inclusion criteria: Age: more than or equal to 60 years,ASA class I - III, all patients undergoing diagnostic or therapeutic bronchoscopy,patients giving consent for procedure will be considered for the study
Exclusion criteria
Exclusion criteria: 1.Patient has already undergone any thoracic surgery in the past 2. Patient with ventilated support 3. Severe cardiac diseases 4. Known previous allergy to any drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extubation time in the elderly patient undergoing rigid bronchoscopyTimepoint: At time of extubation of trachea | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare perioperative vitals between the groups ,to compare any complications following administration of of Sugammadex and Neostigmine such as hypotension, laryngospasm, apnea, pneumonia, atelectasis etc and to compare postoperative breath-holding time (BHT) following neuromuscular blockade reversal with Sugammadex versus Neostigmine, measured at 15 and 30 minutes after extubation, in comparison to preoperative BHTTimepoint: During intraoperative period and 1 hour of post extubation in the post anaesthesia care unit | — |
Countries
India
Contacts
Public ContactDr Mridul Dhar
All India Institute of Medical Sciences- Rishikesh- Rishikesh
Outcome results
None listed